Autumn Newsletter

12 November 2019

Autumn Newsletter
Back to News

Read on to catch-up with the AvantiCell latest. While we take this opportunity to look back on our recent months, we look forward to the changes and challenges that come with the arrival of Autumn.  Read on to catch-up with the AvantiCell latest.


ACS Goes Yellow for ACS


Last month AvantiCell Science took part in Ayrshire Cancer Support’s Go Yellow Day.
This fantastic local charity aims to offer support to patients and their families during their time of need.

The AvantiCell team had a bit of fun on the day but hope we were able to raise some awareness locally on the importance of this charity while raising the kind donations of staff.


Fibrosis Technology Overview

AvantiCell’s fibrosis models evaluate test materials for their potential to cause tissue damage by induction of fibrosis or for their potential anti-fibrotic activity. Analysis is based upon fibroblast to myofibroblast conversion by cell population analysis, direct measurement of extracellular matrix deposition and/or upregulation of key genes involved in fibrosis pathogenesis.


Using our own primary fibroblasts, we have built a platform that offers flexible and scalable analysis of fibrotic and anti-fibrotic activity. Read our Technology Overview for more details and contact us to discuss your project requirements. All projects are entirely customisable.





New Team Members

The AvantiCell Team welcomed Chemistry with Drug Discovery graduate Rebecca in August and we are delighted she had joined the lab. Following our training programme, Rebecca will join our contract services team and will also help our with our primary cell isolations. Find out more about Rebecca and the new skills she brings to AvantiCell in our Q&A.




AvantiCell is also thrilled that PANDORA ESR Alessandra Prinelli will be staying with the AvantiCell team as a member of staff to continue her fantastic work on immune cells and immune cell-based analysis for our customers.




Need Access to Immune Cells?


We are developing a new line of human immune cell products isolated from ethically-sourced whole blood fractions.


In August we announced the availability of PBMCs, and just next week our CD14+ monocytes will become available. These cells provide the starting material for monocyte-derived macrophages and dendritic cells and have applications in phagocytosis research.


Off-The-Shelf or Made-To-Order, our high-quality immune cells are isolated from NHS-sources and suitable for your research needs. You can specify your donor criteria or purchase our immediately-available frozen vials. With with modest stocks and reservation of vials available, you can return to the same batch whenever your research requires.


You can view our datasheets online or contact us for more information.




Good Things Come To Those Who Collaborate


Recently, AvantiCell’s TRANSMIT ESR Catarina has been travelling for various training opportunities across Europe. She spent 2 months in Salzberg on secondment in Dr. Barbara Kofler’s lab at the Paracelsus Medical University Salzburg.


Catarina wrote a weekly blog while she was away and you can find out about the new techniques she learnt and more about her experience in her LinkedIn article.




Cancer Drug Discovery




13 years ago, AvantiCell began with our focus on supporting the discovery of new cancer therapeutics through the use of primary cancer cells. While our technology has evolved greatly since then, our focus on cancer has remained and soon we will be adding to our current primary cancer cell portfolio.


So if your research is focused on ovarian or cervical cancers, and you wish to be the first to hear about additional donors of these cells, contact us.


Tweet Tweet!


Twitter is increasingly being used to initiate scientific discussions, allowing researchers to share their knowledge and scientific views. Each month we kick-off out very own #Sciencebites discussion with changing themes each month. Follow our Twitter account to keep up with the conversation and take par                    


Articles we've shared:


Immune cell function in cancer immunotherapy revealed, August 2019


Health implications of the baby biome? September 2019


Woman Receives First Corneal Transplant Made from iPS Cell, September 2019


We're making tiny brains in the lab — should we be worried for them? October 2019


Patient-derived organoids help predict how patients respond to chemotherapy, October 2019